James J. O'Brien acquires 1,450 EMN shares; Form 4 disclosure

Rhea-AI Filing Summary

James J. O'Brien, a director of Eastman Chemical Company (EMN), reported a purchase of company shares. On 08/27/2025 he acquired 1,450 shares of Common Stock at a price of $68.811 per share. After the transaction he beneficially owned 6,828 shares directly and had an indirect interest in 1,022 shares held in a revocable trust. The Form 4 was signed by Mark D. Austin by power of attorney on 08/28/2025.

Positive

• Insider purchase disclosed with specific price and share count, improving transparency
• Both direct and indirect holdings are reported, clarifying ownership structure
• Form signed via power of attorney and dated, indicating procedural compliance

Negative

• None.

Insights

Financial Analyst

TL;DR: Director purchased 1,450 EMN shares at $68.811; holdings updated to 6,828 direct and 1,022 indirect.

The filing documents an open-market or private purchase (transaction code P) of 1,450 common shares on 08/27/2025 at $68.811 each. The report shows both direct and indirect beneficial ownership, with the indirect stake held via a revocable trust. The filing is routine Form 4 disclosure updating insider ownership; it provides clear price and post-transaction holdings but no context on funding source or intent.

Corporate Governance Expert

TL;DR: Routine insider purchase reported; properly documented with POA signature.

The Form 4 identifies the reporting person as a director and records a purchase under transaction code "P," meeting Section 16 disclosure requirements. The signature by an attorney-in-fact (Mark D. Austin) is noted and dated 08/28/2025. The form discloses direct and revocable-trust indirect ownership, satisfying transparency expectations for insider trades. No amendments or corrective statements are indicated.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OBRIEN JAMES J /KY

(Last) (First) (Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		P		1,450	A	$68.811	6,828	D
Common Stock								1,022	I	By Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for James J. O'Brien	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did James J. O'Brien report on the Form 4 for EMN?

The Form 4 reports that James J. O'Brien acquired 1,450 shares of Eastman Chemical Company common stock on 08/27/2025 at a price of $68.811 per share.

How many EMN shares does James J. O'Brien beneficially own after the reported transaction?

After the transaction he beneficially owns 6,828 shares directly and has an indirect interest in 1,022 shares held via a revocable trust.

What relationship does the reporting person have to Eastman Chemical (EMN)?

The filing indicates the reporting person, James J. O'Brien, is a Director of Eastman Chemical Company.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Mark D. Austin, by Power of Attorney for James J. O'Brien on 08/28/2025.

What transaction code was used on the Form 4 and what does it signify?

The filing shows transaction code "P", which on the form indicates a purchase of securities.